Established in 1980, the MIC has answered over 200 000 queries from health care workers and we’ve done it well. During this time, the centre has been funded by a range of generous funders. Our current funding, kind favour of the Global Fund and Western Cape Department of Health ends in March 2019, so we’re on the hunt for more generous funders. Please, if you are one of those, or you know of anyone/any organisation that is, let us know.
It’s hard to believe that we’ve been running the hotline for ten years, but we have. And we’re very proud of the work we do and look forward to many more years of doing it.
The FDA is requiring the addition of a new warning to the lamotrigine prescribing information of a rare, but very serious adverse reaction called hemophagocytic lymphohistiocytosis (HLH).
Early data from a study in Botswana has shown an increased risk in neural tube defects in babies born to mothers taking dolutegravir during pregnancy, prompting worldwide warnings against its use in pregnancy and women of child-bearing age.